This has been previously shown in animal studies, in which anti-PD-L1 antibody treatment demonstrated a significant increase in T cell infiltration in colon cancer bearing mice, suggesting that PD-L1 blockade is an effective strategy to increase CD8+ T cell infiltration [39]. This evidence concerns the gene CD8A and colonic neoplasm.